Related Experiment Videos
Spinal cord stimulation for relief of ischemic pain in end-stage arterial occlusive disease
Insights
Spinal cord stimulators offer a potential treatment for end-stage arterial occlusive disease. Success rates vary, with 67% of patients without ulcers improving, compared to 38% with foot lesions.
Area of Science:
- Vascular Surgery
- Neuromodulation
- Pain Management
Background:
- End-stage arterial occlusive disease (EAOD) poses significant challenges for patients with limited surgical options.
- Spinal cord stimulation (SCS) has emerged as a potential therapeutic modality for intractable limb pain.
- Previous research on SCS for vascular conditions is limited, necessitating further investigation.
Purpose of the Study:
- To evaluate the efficacy and safety of spinal cord stimulator implantation in patients with EAOD.
- To determine success rates based on disease severity and wound presence.
- To assess the impact of SCS on limb salvage and pain reduction.
Main Methods:
- A prospective study involving 41 patients with EAOD unsuitable for surgery.
- Patients received SCS implantation and were followed for up to 6 months.
- Patient outcomes were classified using the Society for Vascular Surgery/Society for Cardiovascular Surgery reporting standards (1986).
Main Results:
- Out of 25 patients followed, 67% with rest pain and no ulcers (grade II) showed successful treatment.
- Patients with rest pain and foot lesions had a lower success rate of 38%.
- Failure was defined as limb amputation or major reconstructive surgery.
Conclusions:
- Spinal cord stimulation demonstrates potential as a treatment for selected patients with end-stage arterial occlusive disease.
- Early-stage disease without critical ischemic complications shows higher success rates.
- Further research is warranted to optimize patient selection and treatment protocols for SCS in vascular disease.
Abstract:
A total of 41 patients with end-stage arterial occlusive disease not treatable by surgery were enrolled in a study after implantation of a spinal cord stimulator. To date, a total of 25 patients have been followed up to 6 months after surgery. Patients were classified as grade I to grade III based on the scale developed by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/Society for Cardiovascular Surgery (1986). Sixty-seven percent of patients with rest pain who did not have ulcers (grade II) were successfully treated with a spinal cord stimulator. The success rate among patients who had rest pain and foot lesions was only 38%. Failure is defined as foot amputation or heroic bypass surgery. This study was conducted at six centers in North America.